Print

Immunicum Recruits a New Chief Operating Officer  
7/1/2013 7:44:29 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Immunicum AB (publ), which develops therapeutic cancer vaccines, has appointed Henrik Elofsson as new Chief Operating Officer (COO).

As COO, Henrik Elofsson will be responsible for project management regarding preclinical and clinical trials. He will also be responsible for the establishment of a large-scale production process.

Help employers find you! Check out all the jobs and post your resume.

//-->